Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Plos Medicine|June 18, 2021
PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trialConnie Celum, Sybil Hosek, Mandisa Tsholwana, et al.
Plos One|May 9, 2017
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052Philip J Palumbo, Ethan A Wilson, Estelle Piwowar-Manning, et al.
JMIR Research Protocols|June 18, 2025
Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator-Delivered Integrated Prevention Package (HPTN 112-NJIRA Study)Sarah E Rutstein, Laura Limarzi-Klyn, Jane S Chen, et al.
Open Forum Infectious Diseases|November 3, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083Hannah P Moore, Jessica M Fogel, Mark A Marzinke, et al.
AIDS Research and Human Retroviruses|October 28, 2024
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2026
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083Raphael J Landovitz, Jessica M Fogel, Fei Gao, et al.
The Journal of Infectious Diseases|August 3, 2013
Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052)Jessica M Fogel, Lei Wang, Teresa L Parsons, et al.
HIV Clinical Trials|April 8, 2017
Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H Eshleman, Ethan A Wilson, Xinyi C Zhang, et al.
The Journal of Infectious Diseases|March 19, 2021
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Beatriz Grinsztejn, Jessica M Fogel, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2023
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Jessica M Fogel, Zhe Wang, et al.
Pageof 18